Taiho Pharmaceutical Co., Ltd.
Clinical trials sponsored by Taiho Pharmaceutical Co., Ltd., explained in plain language.
-
New pill targets rare genetic flaw in Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental drug (TAS0953/HM06) in adults with advanced solid tumors that have a specific RET gene abnormality. The first part finds the safest dose; the second part measures how well the drug shrinks tumors. About 244 people will take part.
Phase: PHASE1, PHASE2 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 07:57 UTC
-
Could a pill replace needles for MDS treatment?
Disease control Recruiting nowThis early-stage study tests an oral combination drug (ASTX030) for people with myelodysplastic syndrome (MDS), a blood disorder. The goal is to see if the pill form works as well as the standard injection. About 40 adults with MDS will take the drug by mouth, and researchers wil…
Phase: PHASE1 • Sponsor: Taiho Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC